Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Aclaris Therapeutics (ACRS): Strategic Alliance with Biosion Ignites 53% Stock Surge
Sintx Technologies, Inc. (SINT): A Bold Move with Strategic Stock Repurchase…
HCW Biologics Inc. (HCWB): A Strategic Leap with Worldwide Licensing Agreement…
Viking Therapeutics (VKTX): Is This Weight Loss Drug Contender Worth Buying…
RadNet, Inc. (RDNT): Strategic Collaboration with GE HealthCare Boosts Stock by…
Finance
Singular Genomics (OMIC) Surges Over 65% Following recent Acquisition Proposal from…
Monte Rosa Therapeutics Soars on Novartis Deal: A Molecular Glue Revolution
Betforward: A Gateway to Sports Betting and Online Gaming
Aligos Therapeutics ($ALGS): A Bold Move to Regain Nasdaq Compliance
Portage Biotech Inc. (NASDAQ: PRTG): A Closer Look at a Tumultuous…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:RGLS
Tag: NASDAQ:RGLS
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan...
Kate Hudson
-
July 1, 2022
0
Regulus Therapeutics Inc (NASDAQ: RGLS) Will Start a Trial for miR-155
Matt Wade
-
April 8, 2022
0
Regulus Therapeutics Inc. (NASDAQ: RGLS) strategically Prioritizing RGLS8429 for Autosomal Dominate...
Kate Hudson
-
October 18, 2021
0
Regulus Therapeutics Inc. (NASDAQ:RGLS) Reports Its Q3 2020 Financial Results Boosted...
Gavins Felicity
-
November 20, 2020
0
Recent Post
Aclaris Therapeutics (ACRS): Strategic Alliance with Biosion Ignites 53% Stock Surge
Ash K
-
November 18, 2024
0
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) experienced a remarkable 53.17% spike in its stock price, closing at $3.14 on November 18, 2024, following...
Sintx Technologies, Inc. (SINT): A Bold Move with Strategic Stock Repurchase...
November 18, 2024
HCW Biologics Inc. (HCWB): A Strategic Leap with Worldwide Licensing Agreement...
November 18, 2024
Viking Therapeutics (VKTX): Is This Weight Loss Drug Contender Worth Buying...
November 11, 2024
RadNet, Inc. (RDNT): Strategic Collaboration with GE HealthCare Boosts Stock by...
November 11, 2024
romabet
mahbet
پین باهیس
bettingmagazine.org
بت کارت
یاس بت
yekbet
megapari
onjabet
alvinbet
betboro
betfa
بت فوروارد
1xbet
1win
betwinner
4shart.com
1xbetgiris.cam
وان کیک بت
وین بت
ریتزوبت
1xbet-ir.com.co
وان ایکس بت
بت فوروارد